2‐Arachidonoylglycerol ‐mediated endocannabinoid signaling modulates mechanical hypersensitivity associated with alcohol withdrawal in mice
Alcoholism: Clinical and Experimental Research · 2022-11 · 46 (11) · 2010-2024
DOI: 10.1111/acer.14949 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alcoholism: Clinical and Experimental Research, online erschienen am 12.10.2022. Verfasst von Amanda Morgan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Alcoholism, Substance Withdrawal Syndrome. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAAA NIH HHS, National Institute on Alcohol Abuse and Alcoholism.
Abstract (Originalsprache)
Background
Alcohol use disorder (AUD) commonly occurs in patients with chronic pain, and a major barrier to achieving abstinence and preventing relapse is the emergence of hyperalgesia during alcohol withdrawal. Elucidating novel therapeutic approaches to target hyperalgesia associated with alcohol withdrawal could have important implications for treating AUD. Here, we examined the role of 2‐arachidonoylglycerol (2‐AG)‐mediated endocannabinoid (eCB) signaling in the regulation of hyperalgesia associated with alcohol withdrawal in mice. We tested the hypothesis that pharmacological augmentation of 2‐AG signaling could reduce hyperalgesia during withdrawal.
Methods
Male and female C57BL/6J mice were tested during withdrawal from a continuous access two‐bottle choice (2BC) paradigm to investigate how eCB signaling modulates mechanical and thermal sensitivity during withdrawal. Mice were pretreated with the monoacylglycerol lipase (MAGL) inhibitor JZL184 to elevate levels of 2‐AG. Rimonabant or AM630 were given to block CB 1 and CB 2 receptor activity, respectively. DO34 was given to reduce 2‐AG by inhibiting the 2‐AG synthetic enzyme diacylglycerol lipase (DAGL).
Results
After 72 h of withdrawal, male and female mice exhibited increased mechanical, but not thermal, hypersensitivity, which normalized by 7 days. This effect was reversed by pretreatment with JZL184. The effects of JZL184 were prevented by coadministration of either the CB 1 or the CB 2 antagonist. DO34, Rimonabant, and AM630 exacerbated mechanical hypersensitivity during alcohol withdrawal, causing an earlier onset and persistent hypersensitivity even 1 week into withdrawal.
Conclusions
Our findings demonstrate the critical role of 2‐AG signaling in the bidirectional regulation of mechanical sensitivity during alcohol withdrawal, with enhancement of 2‐AG levels reducing sensitivity, and inhibition of 2‐AG signaling exacerbating sensitivity. These data suggest that 2‐AG augmentation represents a novel approach to the treatment of alcohol withdrawal‐associated hyperalgesia and AUD in patients with comorbid pain disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
- Vanderbilt Brain Institute, Vanderbilt University, Nashville, Tennessee, USA.
- Interdisciplinary Program in Neuroscience, Vanderbilt University, Nashville, Tennessee, USA.
ORCID-Profile: Sachin Patel
Förderung
- NIAAA NIH HHS
- National Institute on Alcohol Abuse and Alcoholism
Zitieren
APA
Morgan, A., Adank, D., Johnson, K., Butler, E., & Patel, S. (2022). 2‐Arachidonoylglycerol ‐mediated endocannabinoid signaling modulates mechanical hypersensitivity associated with alcohol withdrawal in mice. Alcoholism: Clinical and Experimental Research, 46(11), 2010-2024. https://doi.org/10.1111/acer.14949
Vancouver
Morgan A, Adank D, Johnson K, Butler E, Patel S. 2‐Arachidonoylglycerol ‐mediated endocannabinoid signaling modulates mechanical hypersensitivity associated with alcohol withdrawal in mice. Alcoholism: Clinical and Experimental Research. 2022;46(11):2010-2024. doi:10.1111/acer.14949
BibTeX
@article{Morgan2022,
author = {Morgan, Amanda and Adank, Danielle and Johnson, Keenan and Butler, Emily and Patel, Sachin},
title = {2‐Arachidonoylglycerol ‐mediated endocannabinoid signaling modulates mechanical hypersensitivity associated with alcohol withdrawal in mice},
journal = {Alcoholism: Clinical and Experimental Research},
year = {2022},
volume = {46},
number = {11},
pages = {2010--2024},
doi = {10.1111/acer.14949}
}
EUVIMED